Sexual dimorphism of the increment rate of age-specific incidence of actinic keratoses: an observational, single-centre study.

Autor: Exadaktylou D; Dermatology Department, General Hospital of West Attica 'Aghia Varvara' - General Hospital of Nikaia-Piraeus, Piraeus, Greece., Ioannidou A; Dermatology Department, General Hospital of West Attica 'Aghia Varvara' - General Hospital of Nikaia-Piraeus, Piraeus, Greece., Spyridonos P; Department of Medical Physics, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece., Tsele E; Dermatology Department, General Hospital of West Attica 'Aghia Varvara' - General Hospital of Nikaia-Piraeus, Piraeus, Greece., Bassukas I; Department of Skin and Venereal Diseases, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece.

Publikováno v: European journal of dermatology : EJD [Eur J Dermatol] 2024 Apr 01; Vol. 34 (2), pp. 203-205.

Phase 2 open-label, multicenter, single-arm study of cemiplimab in patients with locally advanced basal cell carcinoma after hedgehog inhibitor therapy: Extended follow-up.

Autor: Stratigos AJ; Department of Dermatology-Venereology, Andreas Sygros Hospital-National and Kapodistrian University of Athens, Athens, Greece. Electronic address: alstrat2@gmail.com., Sekulic A; Department of Dermatology, Arizona Mayo Clinic, Scottsdale, Arizona., Peris K; Dipartimento di Scienze Mediche e Chirurgiche, UOC di Dermatologia, Fondazione Policlinico Universitario A. Gemelli - IRCCS, Rome, Italy., Bechter O; Department of General Medical Oncology, University Hospitals, Leuven, Belgium., Prey S; Department of Dermatology, Bordeaux University Hospital, Bordeaux, France., Lewis KD; School of Medicine, University of Colorado, Aurora, Colorado., Basset-Seguin N; Department of Dermatology, Hôpital Saint-Louis, Paris, France., Chang ALS; Department of Dermatology, Stanford University School of Medicine, Stanford, California., Dalle S; Department of Dermatology, Centre Hospitalier Lyon-Sud, Lyon, France., Fernández Orland A; Department of Dermatology, Hospital Universitario Virgen Macarena, Seville, Spain., Licitra L; Medical Oncology Head and Neck Cancer Department, Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan, Milan, Italy., Robert C; Dermatology Unit, Gustave Roussy Cancer Center and Paris-Saclay University, Villejuif, France., Ulrich C; Skin Cancer Centre, Charite-Universitätsmedizin Berlin, Berlin, Germany., Hauschild A; Department of Dermatology, University of Kiel, Kiel, Germany., Migden MR; Departments of Dermatology and Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas., Dummer R; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland., Yoo SY; Regeneron Pharmaceuticals, Inc, Tarrytown, New York., Okoye E; Regeneron Pharmaceuticals, Inc, Tarrytown, New York., Bassukas I; Faculty of Medicine, Department of Skin and Venereal Diseases, School of Health Sciences, University of Ioannina, Ioannina, Greece., Loquai C; Department of Dermatology, University Medical Center Mainz, Mainz, Germany., De Giorgi V; Departments of Dermatology, Human Pathology, and Oncology, University of Florence, Florence, Italy., Eroglu Z; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida., Gutzmer R; Johannes Wesling Medical Center, Ruhr University Bochum, Minden, Germany., Ulrich J; Academic Teaching Hospital of the University Otto von Guericke Magdeburg, Quedlinburg, Germany., Puig S; Dermatology Department, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain., Inocencio TJ; Regeneron Pharmaceuticals, Inc, Tarrytown, New York., Chen CI; Regeneron Pharmaceuticals, Inc, Tarrytown, New York., LaFontaine PR; Sanofi, Cambridge, Massachusetts., Seebach F; Regeneron Pharmaceuticals, Inc, Tarrytown, New York., Lowy I; Regeneron Pharmaceuticals, Inc, Tarrytown, New York., Fury MG; Regeneron Pharmaceuticals, Inc, Tarrytown, New York.

Publikováno v: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Feb; Vol. 90 (2), pp. 414-418. Date of Electronic Publication: 2023 Oct 14.

A single‐centre retrospective comparison of immunocryosurgery with standard surgical excision for the treatment of non‐superficial, head and neck basal cell carcinoma.

Autor: Gaitanis, G., Seretis, K., Zampeta, A., Spyridonos, P., Bassukas, I. D.

Publikováno v: Journal of the European Academy of Dermatology & Venereology; Feb2024, Vol. 38 Issue 2, pe134-e136, 3p

The Promise of Semantic Segmentation in Detecting Actinic Keratosis Using Clinical Photography in the Wild.

Autor: Derekas P; Department of Computer Science & Engineering, School of Engineering, University of Ioannina, 45110 Ioannina, Greece., Spyridonos P; Department of Medical Physics, Faculty of Medicine, School of Health Sciences, University of Ioannina, 45110 Ioannina, Greece., Likas A; Department of Computer Science & Engineering, School of Engineering, University of Ioannina, 45110 Ioannina, Greece., Zampeta A; Department of Skin and Venereal Diseases, Faculty of Medicine, School of Health Sciences, University of Ioannina, 45110 Ioannina, Greece., Gaitanis G; Department of Skin and Venereal Diseases, Faculty of Medicine, School of Health Sciences, University of Ioannina, 45110 Ioannina, Greece., Bassukas I; Department of Skin and Venereal Diseases, Faculty of Medicine, School of Health Sciences, University of Ioannina, 45110 Ioannina, Greece.

Publikováno v: Cancers [Cancers (Basel)] 2023 Oct 05; Vol. 15 (19). Date of Electronic Publication: 2023 Oct 05.

Effectiveness and safety of apremilast in biologic-naive patients with moderate psoriasis treated in routine clinical practice in Greece: the APRAISAL study

Autor: Ioannides, D. Antonakopoulos, N. Georgiou, S. Chasapi, V and Katsantonis, I Drosos, A. Rigopoulos, D. Antoniou, C. and Anastasiadis, G. Bassukas, I Ioannidou, D. Protopapa, A. and Neofotistou, O. Krasagakis, K. Aronis, P. Papageorgiou, M. and Lazaridou, E. Patsatsi, A. Lefaki, I Roussaki-Schulze, V, A. Satra, F. Anagnostopoulos, Z. Papakonstantis, M.

Background Apremilast is an oral phosphodiesterase-4 inhibitor indicated for patients with moderate-to-severe chronic plaque psoriasis and active psoriatic arthritis. Objectives To examine the effectiveness of apremilast on Dermatology Life Quality I

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::2ba20e1eb2903bfbc5d6af2221d2f998
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3030070